Disclosures
ALBERT
Dr. Matthew Albert received consulting fees/research support from Astellas; Dr. Pauline Gerritsen-van Schieveen, Dr. Na Cai, Dr. Jeffrey Raizer, and Ms. Leticia Delgado-Herrera were employees of Astellas at the time of the study; Dr. Shin Takusagawa and Mr. Tomoyoshi Kishimoto are employees/stockholders of Astellas. Ms. Leticia Delgado-Herrera and Dr. Shin Takusagawa have a patent pending for pharmaceutical composition for imaging; Mr. John Fengler is an employee/stockholder and has patents planned, issued, or pending with Stryker; Dr. Jennifer Paruch has no conflicts of interest or financial ties to disclose.